Xlife Sciences AG
SIX:XLS

Watchlist Manager
Xlife Sciences AG Logo
Xlife Sciences AG
SIX:XLS
Watchlist
Price: 25.4 CHF 3.67% Market Closed
Market Cap: 146.6m CHF

Profitability Summary

Xlife Sciences AG's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Xlife Sciences AG

Revenue
839.4k CHF
Cost of Revenue
-317.5k CHF
Gross Profit
521.9k CHF
Operating Expenses
-20m CHF
Operating Income
-19.5m CHF
Other Expenses
50.2m CHF
Net Income
30.8m CHF

Margins Comparison
Xlife Sciences AG Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CH
Xlife Sciences AG
SIX:XLS
145.8m CHF
62%
-2 318%
3 664%
US
PerkinElmer Inc
LSE:0KHE
1.1T USD
55%
13%
8%
US
Thermo Fisher Scientific Inc
NYSE:TMO
216.1B USD
41%
18%
15%
US
Danaher Corp
NYSE:DHR
160.5B USD
60%
19%
14%
CH
Lonza Group AG
SIX:LONN
35.6B CHF
33%
15%
10%
US
Agilent Technologies Inc
NYSE:A
39.6B USD
52%
21%
19%
US
IQVIA Holdings Inc
NYSE:IQV
37.7B USD
34%
14%
8%
CN
WuXi AppTec Co Ltd
SSE:603259
269B CNY
45%
30%
34%
KR
Samsung Biologics Co Ltd
KRX:207940
45.1T KRW
56%
37%
29%
US
Mettler-Toledo International Inc
NYSE:MTD
28.4B USD
60%
28%
21%
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.1B EUR
46%
17%
9%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Xlife Sciences AG Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CH
Xlife Sciences AG
SIX:XLS
145.8m CHF
11%
6%
-4%
-5%
US
PerkinElmer Inc
LSE:0KHE
1.1T USD
3%
2%
3%
3%
US
Thermo Fisher Scientific Inc
NYSE:TMO
216.1B USD
13%
7%
9%
8%
US
Danaher Corp
NYSE:DHR
160.5B USD
7%
4%
7%
5%
CH
Lonza Group AG
SIX:LONN
35.6B CHF
8%
4%
7%
5%
US
Agilent Technologies Inc
NYSE:A
39.6B USD
21%
11%
15%
13%
US
IQVIA Holdings Inc
NYSE:IQV
37.7B USD
20%
5%
11%
8%
CN
WuXi AppTec Co Ltd
SSE:603259
269B CNY
24%
18%
20%
15%
KR
Samsung Biologics Co Ltd
KRX:207940
45.1T KRW
14%
9%
15%
10%
US
Mettler-Toledo International Inc
NYSE:MTD
28.4B USD
-414%
24%
50%
29%
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.1B EUR
7%
3%
7%
5%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less